Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28.14 | 2 | 70.3% |
| Education | $11.90 | 1 | 29.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $16.24 | 1 | $0 (2018) |
| Eisai Inc. | $11.90 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $11.90 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $40.04 | 3 | AstraZeneca Pharmaceuticals LP ($16.24) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 06/19/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,531 | 3,544 | $530,280 | $175,183 |
| 2022 | 26 | 1,923 | 4,434 | $441,510 | $182,105 |
| 2021 | 28 | 2,222 | 5,357 | $488,741 | $204,629 |
| 2020 | 28 | 2,108 | 4,712 | $381,171 | $162,894 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 330 | 779 | $190,825 | $62,390 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 255 | 503 | $83,129 | $27,479 | 33.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,141 | $86,673 | $20,970 | 24.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 172 | 172 | $48,104 | $20,783 | 43.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 51 | 51 | $56,837 | $14,369 | 25.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 106 | 112 | $11,185 | $7,995 | 71.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 112 | 119 | $4,403 | $3,377 | 76.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 11 | 42 | $6,636 | $3,295 | 49.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $6,290 | $2,332 | 37.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 16 | 16 | $2,596 | $1,926 | 74.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 38 | 45 | $5,715 | $1,888 | 33.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 143 | 212 | $3,090 | $1,781 | 57.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 58 | 58 | $2,146 | $1,646 | 76.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 36 | 39 | $3,862 | $1,350 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,675 | $938.90 | 25.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 22 | $3,410 | $933.28 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,371 | $486.52 | 35.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 53 | $2,014 | $437.64 | 21.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 23 | 24 | $1,197 | $389.28 | 32.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 20 | 43 | $4,674 | $184.55 | 3.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 18 | 24 | $1,978 | $126.28 | 6.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 43 | 47 | $470.00 | $103.40 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 344 | 766 | $170,818 | $59,014 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 355 | 710 | $111,470 | $38,733 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 241 | 241 | $50,610 | $29,692 | 58.7% |
About Dr. Hesamodin Borhani, M.D
Dr. Hesamodin Borhani, M.D is a Internal Medicine healthcare provider based in Trenton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912930975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hesamodin Borhani, M.D has received a total of $40.04 in payments from pharmaceutical and medical device companies, with $40.04 received in 2018. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($28.14).
As a Medicare-enrolled provider, Borhani has provided services to 7,784 Medicare beneficiaries, totaling 18,047 services with total Medicare billing of $724,811. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Trenton, MO
- Active Since 07/09/2006
- Last Updated 10/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912930975
Products in Payments
- BYDUREON (Drug) $16.24
- Belviq (Drug) $11.90
- ENTRESTO (Drug) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Trenton
Dr. Jane Rohlf, Md, MD
Internal Medicine — Payments: $66,501
Dr. Edward Laub, M.d, M.D
Internal Medicine — Payments: $49,453
Sofia Mavasheva
Internal Medicine — Payments: $21,086
Dr. Anuj Chandra, M.d, M.D
Internal Medicine — Payments: $19,972
Iradj Sharim, M.d, M.D
Internal Medicine — Payments: $14,940
Nilesh Rana, Md, MD
Internal Medicine — Payments: $11,392